Azenta Completes Sale of B Medical Systems to Thelema S.à r.l.

Azenta Acquires UK Biocentre Limited to Expand European Biorepository Capabilities

March 6, 2026

Healthcare Services

Azenta, via its wholly owned subsidiary Azenta UK Ltd, acquired UK Biocentre Limited for £20.5 million (net of cash), including up to £1.8 million in contingent milestone consideration. The acquisition expands Azenta’s UK and broader European sample management, storage, and high-throughput processing capabilities, with UK Biocentre intended to serve as a European operational hub supporting life sciences customers.

Tactile Medical Acquires LymphaTech

February 19, 2026

Medical Devices

Tactile Systems Technology (doing business as Tactile Medical) acquired LymphaTech, Inc. for an upfront cash payment of $6.8 million plus potential milestone-based consideration to expand its lymphedema solutions into digital and connected care. LymphaTech co-founders joined Tactile to support commercial adoption and R&D as Tactile integrates the company’s 3D measurement and monitoring platform into its portfolio.

AstraZeneca to Acquire EsoBiotec

March 18, 2025

Biotechnology

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company developing in vivo cell therapies. The deal is valued at up to $1 billion on a cash and debt-free basis, with an initial $425 million payment upon closing plus up to $575 million in contingent milestone consideration. The transaction is expected to close in Q2 2025, subject to regulatory approvals.

biote Corp Acquires Asteria Health

January 17, 2024

Healthcare Services

biote Corp. (NASDAQ: BTMD) announced a definitive agreement to acquire F.H. Investments, Inc., doing business as Asteria Health, a privately held 503B manufacturer of compounded bioidentical hormones. The deal is intended to strengthen biote’s control over its supply chain through vertical integration of hormone product manufacturing and expand biote’s capabilities in 503B manufacturing and product development.

Azenta, Inc. Acquires Ziath, Ltd.

February 3, 2023

Medical Devices

Azenta, Inc. (Nasdaq: AZTA) has acquired Ziath, Ltd., a Cambridge, UK–based provider of 2D barcode readers for life sciences laboratory applications. Ziath will join Azenta's Life Sciences Products business (Consumables and Instruments); CEO and co-founder Neil Benn will continue to lead the business, and the deal is expected to be accretive to non-GAAP earnings in FY2023 and GAAP earnings in FY2024.

Boston Scientific Acquires Xlumena

April 1, 2015

Medical Devices

Boston Scientific agreed to acquire Mountain View–based medical device company Xlumena, gaining the AXIOS and HOT AXIOS stent and delivery systems. The deal includes $62.5 million upfront, $12.5 million contingent on FDA clearance of HOT AXIOS and additional sales-based milestones, and is intended to expand Boston Scientific's endoscopy and EUS therapeutic capabilities and accelerate global commercialization of the AXIOS platform.